Tokyo, Japan

Toshiaki Nakano

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiaki Nakano. Retrieved from https://idiyas.com/inventor/toshiaki-nakano-a2nkghi8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshiaki Nakano: Innovator in Aminobenzoic Acid Derivatives

Introduction

Toshiaki Nakano is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of aminobenzoic acid derivatives. His work has implications for improving liver function and enhancing immunity.

Latest Patents

Toshiaki Nakano holds a patent for "Novel aminobenzoic acid derivatives, process for preparing the same." This patent describes an aminobenzoic acid derivative represented by a specific formula, which exhibits excellent activity for improving liver function and for potentiating and normalizing immunity. The patent also outlines a process for preparing these derivatives and includes a pharmaceutical composition containing them.

Career Highlights

Nakano is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on innovative research and development in the pharmaceutical sector.

Collaborations

Some of his notable coworkers include Yoshiyuki Ohsugi and Masayoshi Ono. Their collaboration has contributed to advancements in the field of medicinal chemistry.

Conclusion

Toshiaki Nakano's work in aminobenzoic acid derivatives showcases his innovative spirit and dedication to improving health outcomes. His contributions to the pharmaceutical industry are noteworthy and continue to influence research in this area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…